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Abstract 
The dengue virus is the most significant arthropod-borne human pathogen, and an increasing 
number of cases have been reported over the last few decades. Currently neither vaccines nor 
drugs against the dengue virus are available. NS5 methyltransferase (MTase), which is 
located on the surface of the dengue virus and assists in viral attachment to the host cell, is a 
promising antiviral target. In order to search for novel inhibitors of NS5 MTase, we 
performed a computer-aided virtual screening of more than 5 million commercially available 
chemical compounds using two approaches: i) structure-based screening using the crystal 
structure of NS5 MTase and ii) ligand-based screening using active ligands of NS5 MTase. 
Structure-based screening was performed using the LIDAEUS (LIgand Discovery At 
Edinburgh UniverSity) program. The ligand-based screening was carried out using the 
EDULISS (EDinburgh University LIgand Selection System) program. The selection of 
potential inhibitors of dengue NS5 MTase was based on two criteria: the compounds must 
bind to NS5 MTase with a higher affinity than that of active NS5 MTase ligands, such as 
ribavirin triphosphate (RTP) and S-adenosyl-L-homocysteine (SAH); and the compounds 
must interact with residues that are catalytically important for the function of NS5 MTase. 
We found several compounds that bind strongly to the RNA cap site and the S-adenosyl-L-
methionine (SAM) binding site of NS5 MTase with better binding affinities than that of RTP 
and SAH. We analyzed the mode of binding for each compound to its binding site, and our 
results suggest that all compounds bind to their respective binding sites by interacting with, 
and thus blocking, residues that are vital for maintaining the catalytic activity of NS5 MTase. 
We discovered several potential compounds that are active against dengue virus NS5 MTase 
through virtual screening using structure-based and ligand-based methods. These compounds 
were predicted to bind into the SAM binding site and the RNA cap site with higher affinities 
than SAH and RTP. These compounds are commercially available and can be purchased for 
further biological activity tests.  
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